Patents by Inventor Masayuki Muroi

Masayuki Muroi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200274194
    Abstract: The present invention aims to provide an all-solid-state lithium ion secondary battery having a high reliability which does not have a decrease in battery capacity due to absorption of moisture in the air. The all-solid-state lithium ion secondary battery is provided with a battery body having an electrolyte layer between a positive electrode layer and a negative electrode layer, a pair of terminal electrodes respectively connected to the positive electrode layer and the negative electrode layer at both end portions of the battery body, and a moisture-proof layer disposed on surfaces excluding the surfaces to be the terminal electrodes, wherein the moisture-proof layer contains a cured product of a composition containing a polymer compound and metal compound particles.
    Type: Application
    Filed: March 28, 2018
    Publication date: August 27, 2020
    Applicant: TDK CORPORATION
    Inventors: Hiroaki TAKAHATA, Hisaji OYAKE, Masayuki MUROI, Tetsuya UENO
  • Publication number: 20200106125
    Abstract: This solid-state lithium ion rechargeable battery includes a laminated body which includes a positive electrode layer, a negative electrode layer, and a solid electrolyte sandwiched between the positive electrode layer and the negative electrode layer, and a liquid repellent film which is provided to be in contact with the laminated body, in which the liquid repellent film contains a fluorine element and a carbon element, and has a contact angle of 30° or more when an acetic acid aqueous solution is dropped thereon.
    Type: Application
    Filed: March 27, 2018
    Publication date: April 2, 2020
    Applicant: TDK CORPORATION
    Inventors: Tomohiro YANO, Hiroshi SATO, Masayuki MUROI
  • Publication number: 20200067133
    Abstract: An all-solid-state lithium ion secondary battery including: a layered body in which a plurality of electrode layers are laminated with a solid electrolyte layer therebetween, a current collector layer and an active material layer being laminated in each of the electrode layers; and a terminal electrode that is formed such that the terminal electrode is in contact with a side surface of the layered body from which end surfaces of the electrode layers are exposed, in which the terminal electrode contains Cu, and Cu-containing regions are formed at grain boundaries that are present near the terminal electrode among grain boundaries of particles that form the active material layers and the solid electrolyte layer.
    Type: Application
    Filed: March 29, 2018
    Publication date: February 27, 2020
    Applicant: TDK CORPORATION
    Inventors: Hiroshi SATO, Keiko TAKEUCHI, Masayuki MUROI, Taisuke MASUKO, Hisaji OYAKE, Tomohiro YANO
  • Publication number: 20200028215
    Abstract: An all-solid-state lithium ion secondary battery includes a plurality of electrode layers that are laminated with a solid electrolyte layer therebetween, a current collector layer and an active material layer being laminated in each of the electrode layers, the current collector layers contain Cu, and Cu-containing regions are formed at grain boundaries that are present near the current collector layer among grain boundaries of particles that form the active material layer.
    Type: Application
    Filed: March 29, 2018
    Publication date: January 23, 2020
    Applicant: TDK CORPORATION
    Inventors: Hiroshi SATO, Keiko TAKEUCHI, Masayuki MUROI, Taisuke MASUKO, Hisaji OYAKE, Tomohiro YANO
  • Patent number: 5196564
    Abstract: A novel compound of the formula (I): ##STR1## wherein R.sub.1 is esterified carboxyl; R.sub.2, R.sub.3 and R.sub.4 are the same or different and are hydrogen or alkyl; A is formyl, hydroxyiminomethyl or carboxyl; and X is hydrogen or halogen, or a salt thereof, which is useful as an aromatase inhibitor or an intermediate of its production. Processes for producing the compound of the formula (I) and an aromatase inhibitor containing as an active component the compound of the formula (I) wherein A is formyl and X is hydrogen or, a salt thereof as well as Penicillium funiculosum capable for producing the compound (I) wherein R.sub.1 is carboxyl, R.sub.2, R.sub.3 and R.sub.4 are hydrogen and X is formyl are also disclosed.
    Type: Grant
    Filed: February 27, 1991
    Date of Patent: March 23, 1993
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsuneo Kanamaru, Tsuneaki Hida, Masayuki Muroi
  • Patent number: 5147860
    Abstract: The present invention relates to a compound of the formula: ##STR1## wherein X is hydroxyl group or hydrogenatom, or a salt thereof. The compound (I) has an acitivity to inhibit angiogenesis, which is useful for prophylaxis and therapy of various diseases accompanying abnormally increased angiogenesis, especially of tumors.
    Type: Grant
    Filed: December 7, 1989
    Date of Patent: September 15, 1992
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsuneo Kanamaru, Yukimasa Nozaki, Masayuki Muroi
  • Patent number: 5013757
    Abstract: A novel compound of the formula (I): ##STR1## wherein R.sub.1 is optionally esterified or amidated carboxyl; R.sub.2, R.sub.3 and R.sub.4 are the same or different and are hydrogen or alkyl; A is formyl, hydroxyiminomethyl or carboxyl; and X is hydrogen or halogen, or a salt thereof, which is useful as an aromatase inhibitor or an intermediate of its production. Processes for producing the compound of the formula (I) and an aromatase inhibitor containing as an active component the compound of the formula (I) wherein A is formyl and X is hydrogen or, a salt thereof as well as Penicillium funiculosum capable for producing the compound (I) wherein R.sub.1 is carboxyl, R.sub.2, R.sub.3 and R.sub.4 are hydrogen and X is formyl are also disclosed.
    Type: Grant
    Filed: April 13, 1990
    Date of Patent: May 7, 1991
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsuneo Kanamaru, Tsuneaki Hida, Masayuki Muroi
  • Patent number: 4963581
    Abstract: The present invention relates to an aromatase inhibiting composition which contains a compound of the formula: ##STR1## wherein R is hydroxy, lower alkoxy or amino which may be substituted by lower alkyl; R.sup.1 is hydrogen or lower alkyl; and A is hydrogen, a group of the formula ##STR2## in which R.sup.2 is hydroxy, lower alkoxy or amino which may be substituted by lower alkyl and R.sup.3 is hydrogen or lower alkyl, or a group of the formula ##STR3## in which R.sup.4 and R.sup.5 are independently hydrogen or lower alkyl, or a salt thereof.The present composition is useful in the prevention and treatment of estrogen-dependent diseases, such as breast cancer.
    Type: Grant
    Filed: April 5, 1989
    Date of Patent: October 16, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsuneo Kanamaru, Takenori Ishimaru, Masayuki Muroi
  • Patent number: 4935543
    Abstract: A novel compound of the formula (I): ##STR1## wherein R.sub.1 is optionally esterified or amidated carboxyl; R.sub.2, R.sub.3 and R.sub.4 are the same or different and are hydrogen or halogen or alkyl; A is formyl, hydroxyiminomethyl or carboxyl; and A is hydrogen or halogen, or a salt thereof, which is useful as an aromatase inhibitor or an intermediate of its production. Processes for producing the compound of the formula (I) and an aromatase inhibitor containing as an active compound the compound of the formula (I) wherein A is formyl and X is hydrogen or, a salt thereof as well as Penicillium funiculosum capable for producing the compound (I) wherein R.sub.1 is carboxyl, R.sub.2, R.sub.3 and R.sub.4 are hydrogen and X is formyl are also disclosed.
    Type: Grant
    Filed: May 18, 1989
    Date of Patent: June 19, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsuneo Kanamaru, Tsuneaki Hida, Masayuki Muroi
  • Patent number: 4803275
    Abstract: The present invention relates to a compound FA-4283 or its derivative of the formula: ##STR1## wherein R is hydrogen or lower alkyl, and 3,4- and 3',4'-double bond may be saturated with hydrogens, and the method of production thereof.The compound (I) of the invention has an action of inhibiting fatty acid synthesis, thus being useful as an agent for prophylaxis and improvement of disorders of glucose and lipid methabolism.
    Type: Grant
    Filed: September 2, 1987
    Date of Patent: February 7, 1989
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsuneo Kanamaru, Susumu Shinagawa, Masayuki Muroi
  • Patent number: 4540517
    Abstract: A compound of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and each represents hydrogen or methyl and X is ##STR2## provided that when R.sub.1 is hydrogen, R.sub.2 is hydrogen or methyl and X is ##STR3## and when R.sub.1 is methyl, R.sub.2 is methyl and X is ##STR4## is produced by cultivating a a microorganism belonging to the genus Streptomyces in a culture medium. Said compound is useful as an antimicrobial agent and so forth.
    Type: Grant
    Filed: December 2, 1983
    Date of Patent: September 10, 1985
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Seiichi Tanida, Masayuki Muroi, Toru Hasegawa
  • Patent number: 4512975
    Abstract: Macbecin derivatives are produced by cultivating a microorganism of the genus Actinosynnema in a culture medium.The Macbecin derivatives are useful as antibacterial, antifungal or antiprotozoal agent.
    Type: Grant
    Filed: September 14, 1983
    Date of Patent: April 23, 1985
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Toru Hasegawa, Masayuki Muroi, Seiichi Tanida
  • Patent number: 4421688
    Abstract: Macbecin derivatives are produced by bringing Macbecins into contact with a microorganism, or its processed matter, of the genus Streptomyces or Nocardia. The Macbecin derivatives are useful as antibacterial, antifungal or antiprotozoal agent.
    Type: Grant
    Filed: September 2, 1982
    Date of Patent: December 20, 1983
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Masayuki Muroi, Makoto Kida
  • Patent number: 4421687
    Abstract: Macbecin derivatives are produced by cultivating a microorganism of the genus Actinosynnema in a culture medium.The Macbecin derivatives are useful as antibacterial, antifungal or antiprotozoal agent.
    Type: Grant
    Filed: September 2, 1982
    Date of Patent: December 20, 1983
    Assignee: Takeda Chemical Industries, Limited
    Inventors: Toru Hasegawa, Masayuki Muroi, Seiichi Tanida
  • Patent number: 4373028
    Abstract: A novel antibiotic C-14482 A.sub.1 is produced by cultivating a microorganism belonging to the genus Nocardia and capable of producing Antibiotic C-14482 A.sub.1 is a culture medium, whereby Antibiotic C-14482 A.sub.1 is elaborated and accumulated in the culture medium and recovering the same antibiotic.Antibiotic C-14482 A.sub.1 is useful as a germicide or disinfectant.
    Type: Grant
    Filed: July 14, 1981
    Date of Patent: February 8, 1983
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Higashide, Seiichi Tanida, Masayuki Muroi, Mitsuko Asai
  • Patent number: 4298600
    Abstract: A novel antibiotic C-14482 A.sub.1 is produced by cultivating a microorganism belonging to the genus Nocardia and capable of producing Antibiotic C-14482 A.sub.1 in a culture medium, whereby Antibiotic C-14482 A.sub.1 is elaborated and accumulated in the culture medium, and recovering the same antibiotic.Antibiotic C-14482 A.sub.1 is useful as a germicide or disinfectant.
    Type: Grant
    Filed: August 2, 1978
    Date of Patent: November 3, 1981
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Higashide, Seiichi Tanida, Masayuki Muroi, Mitsuko Asai
  • Patent number: 4292309
    Abstract: Novel antibiotics C-14482 B.sub.1, B.sub.2 and B.sub.3 are produced by cultivating a microorganism belonging to the genus Nocardia and capable of producing Antibiotics C-14482 B.sub.1, B.sub.2 and/or B.sub.3 in a culture medium, whereby Antibiotics C-14482 B.sub.1, B.sub.2 and/or B.sub.3 are elaborated and accumulated in the cultured broth and are recovered.Antibiotics C-14482 B.sub.1, B.sub.2 and B.sub.3 are useful as a germicide or disinfectant, respectively.
    Type: Grant
    Filed: January 17, 1980
    Date of Patent: September 29, 1981
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Higashide, Seiichi Tanida, Masayuki Muroi, Mitsuko Asai